Chemoprevention for gastric cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 4-5, 2011, Pages 581-592

  Ford, Alexander C ^a,b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Anti oxidants; Aspirin; Chemoprevention; Gastric cancer; Helicobacter pylori; Non steroidal anti inflammatory drugs; Selenium

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BISMUTH; CLARITHROMYCIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LANSOPRAZOLE; METRONIDAZOLE; MOLYBDENUM; OMEPRAZOLE; SELENIUM;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CAUSE OF DEATH; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; MASS SCREENING; META ANALYSIS (TOPIC); RISK REDUCTION; STOMACH CANCER;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CHEMOPREVENTION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RISK FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 82455171818     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.09.002     Document Type: Article

References (88)

1. J. Ferlay, H.-R. Shin, and F. Bray Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. J. Ferlay, F. Bray, P. Pisani GLOBOCAN Cancer incidence, mortality, and prevalence worldwide. IARC CancerBase No 5, version 2 0 Lyon 2002 IARC Press 2004 2004
3. D. Forman Helicobacter pylori: the gastric cancer problem Gut 43 Suppl. 1 1998 S33 S34
4. E. Lello, B. Furnes, and T.H. Edna Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years Acta Oncol 46 2007 308 315 (Pubitemid 46625033)
5. S.C. Cunningham, F. Kamangar, and M.P. Kim Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution J Gastrointest Surg 9 2005 718 725 (Pubitemid 40603013)
6. M. Degiuli, and F. Calvo Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary? World J Surg 30 2006 2193 2203 (Pubitemid 44885175)
7. N. Vakil, N.J. Talley, and S. Veldhuyzen van Zanten Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms Clin Gastroenterol Hepatol 7 2009 756 761
8. P. Correa, W. Haenszel, and C. Cuello A model for gastric cancer epidemiology Lancet 306 1975 58 60
9. P. Correa The gastric precancerous process Cancer Surv 2 1983 437 450
10. P. Correa, C. Cuello, and E. Duque Gastric cancer in Colombia III: natural history of precursor lesions J Natl Cancer Inst 57 1976 1027 1035
11. J.R. Warren, and B.J. Marshall Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet 321 1983 1273 1275
12. B.J. Marshall, and J.R. Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 323 1984 1311 1315
13. E.J. Kuipers, A.M. Uyterlinde, and A.S. Pena Long-term sequelae of Helicobacter pylori gastritis Lancet 345 1995 1525 1528
14. E.J. Kuipers, G.F. Nelis, and E.C. Klinkenberg-Knol Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial Gut 53 1 2004 12 20 (Pubitemid 38083004)
15. R. Mera, E.T.H. Fontham, and L.E. Bravo Long-term follow-up of patients treated for Helicobacter pylori infection Gut 54 2005 1536 1540 (Pubitemid 41531767)
16. A. Nomura, G.N. Stemmerman, and P.-H. Chyou Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii N Engl J Med 325 1991 1132 1136
17. D. Forman, D.G. Newell, and F. Fullerton Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation Br Med J 302 1991 1302 1305
18. J. Parsonnet, G.D. Friedman, and D.P. Vandersteen Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med 325 1991 1127 1131
19. International Agency for Research on Cancer Schistosomes, liver flukes and Helicobacter pylori IARC Monogr Eval Carcinog Risks Hum 61 1994 177 241
20. H. Tabata, T. Fuchigami, and H. Kobayashi Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori Dig Dis Sci 44 1999 2027 2034 (Pubitemid 29510813)
21. M.J. Blaser, K. Kobayashi, and T.L. Cover Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach Int J Cancer 55 1993 799 802 (Pubitemid 23354897)
22. S. Hansen, K.K. Melby, and S. Aase Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study Scand J Gastroenterol 34 4 1999 353 360 (Pubitemid 29232369)
23. M. Asaka, T. Kimura, and M. Kato Possible role of Helicobacter pylori infection in early gastric cancer Cancer 73 1994 2691 2694 (Pubitemid 24166252)
24. J. Danesh Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies Aliment Pharmacol Ther 13 1999 851 856 (Pubitemid 29312768)
25. Helicobacter and Cancer Collaborative Group Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts Gut 49 3 2001 347 353
26. J. Parsonnet, R.A. Harris, and H.M. Hack Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Lancet 348 1996 150 154 (Pubitemid 26238097)
27. A.M. Fendrick, M.E. Chernew, and R.A. Hirth Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer Arch Intern Med 159 1999 142 148 (Pubitemid 29055101)
28. A. Sonnenberg, and J.M. Inadomi Medical decision models of Helicobacter pylori therapy to prevent gastric cancer Aliment Pharmacol Ther 12 Suppl. 1 1998 111 121
29. J.A. Lane, L.J. Murray, and S. Noble Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol Helicobacter project: randomised controlled trial Br Med J 332 2006 199 202 (Pubitemid 43171698)
30. P. Moayyedi, R. Feltbower, and J. Brown Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial Lancet 355 2000 1665 1669 (Pubitemid 30248477)
31. M. Wildner-Christensen, J. Moller Hansen, and O. Schaffalitzky De Muckadell Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population Gastroenterology 125 2003 372 379 (Pubitemid 36929417)
32. A.C. Ford, D. Forman, and A.G. Bailey A community screening program for Helicobacter pylori saves money: ten-year follow-up of a randomised controlled trial Gastroenterology 129 2005 1910 1917 (Pubitemid 41772968)
33. A.C. Ford, D. Forman, and J. Nathan Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use Aliment Pharmacol Ther 26 2007 1267 1275 (Pubitemid 47620423)
34. P. Correa, E.T.H. Fontham, and J.C. Bravo Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy J Natl Cancer Inst 92 2000 1881 1888 (Pubitemid 32036918)
35. P. Correa, E.T.H. Fontham, and J.C. Bravo Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy Reply J Natl Cancer Inst 93 2001 559 560
36. B.C.Y. Wong, S.K. Lam, and W.M. Wong Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 291 2 2004 187 194 (Pubitemid 38082812)
37. D. Saito, N. Boku, and T. Fujioka Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese intervention trial (JITHP-Study): a randomized multi-center trial Gastroenterology 128 Suppl. 2 2005 A4
38. W.-C. You, L.M. Brown, and L. Zhang Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions J Natl Cancer Inst 98 2006 974 983 (Pubitemid 44288162)
39. J.J.Y. Sung, S.-R. Lin, and J.Y.L. Ching Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study Gastroenterology 119 2000 7 14 (Pubitemid 30452573)
40. W.K. Leung, S.-R. Lin, and J.Y.L. Ching Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication Gut 53 2004 1244 1249 (Pubitemid 39120105)
41. L. Zhou Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China Gastroenterology 134 Suppl. 1 2008 A233
42. K. Fukase, M. Kato, and S. Kikuchi Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 2008 392 397
43. L. Fuccio, R.M. Zagari, and L.H. Eusebi Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151 2009 121 128
44. A.C. Ford, and P. Moayyedi Redundant data in the meta-analysis on Helicobacter pylori eradication Ann Intern Med 151 2009 513
45. Correction: Can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:516.
46. T. Hla, and K. Neilson Human cyclooxygenase-2 cDNA Proc Natl Acad Sci USA 89 1992 7384 7388
47. R.N. Dubois, J. Awad, and J. Morrow Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester J Clin Invest 93 1994 493 498 (Pubitemid 24072787)
48. M. Oshima, J.E. Dinchuk, and S.L. Kargman Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809 (Pubitemid 26404280)
49. M.L. Smith, G. Hawcroft, and M.A. Hull The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action Eur J Cancer 36 2000 664 674 (Pubitemid 30156854)
50. F.M. Giardiello, S.R. Hamilton, and A.J. Krush Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1993 1313 1316 (Pubitemid 23131373)
51. B.F. Cole, R.F. Logan, and S. Halabi Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials J Natl Cancer Inst 101 2009 256 266
52. H. Sawaoka, S. Kawano, and S. Tsuji Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development J Clin Gastroenterol 27 1998 S47 S52
53. G.H. Zhu, B.C. Wong, and M.C. Eggo Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc Br J Cancer 79 1999 393 400 (Pubitemid 29046210)
54. X.M. Zhou, B.C.Y. Wong, and X.M. Fan Non-steroidal antif-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak Carcinogenesis 22 2001 1393 1397 (Pubitemid 32898695)
55. H. Murata, S. Kawano, and S. Tsuji Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma Am J Gastroenterol 94 1999 451 455 (Pubitemid 29084668)
56. D.C. Farrow, T.L. Vaughan, and P.D. Hansten Use of aspirin and other non-steroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomark Prev 7 1998 97 102 (Pubitemid 28109839)
57. K. Akre, A.M. Ekstrom, and L.B. Signorello Aspirin and risk for gastric cancer: a population-based case-control study in Sweden Br J Cancer 84 2001 965 968 (Pubitemid 32385841)
58. M. Lindblad, J. Lagergren, and L.A. Garcia Rodriguez Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomark Prev 14 2005 444 450 (Pubitemid 40270110)
59. L. Duan, A.H. Wu, and J. Sullivan-Halley Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles county Cancer Epidemiol Biomark Prev 17 2008 126 134 (Pubitemid 351196282)
60. C.C. Abnet, N.D. Freedman, and F. Kamangar Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis Br J Cancer 100 2009 551 557
61. M. Epplein, A.M.Y. Nomura, and L.R. Wilkens Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma. The multiethnic cohort study Am J Epidemiol 170 2009 507 514
62. W.H. Wang, J.Q. Huang, and G.F. Zheng Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis J Natl Cancer Inst 95 2003 1784 1791 (Pubitemid 38008901)
63. P. Yang, Y. Zhou, and B. Chen Aspirin use and the risk of gastric cancer: a meta-analysis Dig Dis Sci 55 2010 1533 1539
64. P.M. Rothwell, F.G.R. Fowkes, and J.F.F. Belch Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 2011 31 41
65. C.A. Gonzalez, G. Pera, and A. Agudo Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) Int J Cancer 118 2006 2559 2666
66. K.A. Steinmetz, and J.D. Potter Vegetables, fruit, and cancer. I. Epidemiology Cancer Causes Control 2 1991 325 357
67. C.S. Yang, J. Miao, and W. Yang Diet and vitamin nutrition of the high esophageal cancer risk population in Linxian, China Nutr Cancer 4 1982 154 164 (Pubitemid 13114441)
68. G. Shklar Mechanism of cancer inhibition by anti-oxidant nutrients Oral Oncol 34 1998 24 29 (Pubitemid 28210527)
69. M.P. Rayman Selenium in cancer prevention: a review of the evidence and mechanism of action Proc Nutr Soc 64 2005 527 542 (Pubitemid 41705454)
70. J. Lanfear, J. Fleming, and L. Wu The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 15 1994 1387 1392 (Pubitemid 24217691)
71. C. Jiang, W. Jiang, and C. Ip Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake Mol Carcinog 29 1999 236 250
72. A.M. Ekstrom, M. Serafini, and O. Nyren Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden Int J Cancer 87 2000 133 140 (Pubitemid 30368427)
73. N. Lunet, C. Valbuena, and F. Carneiro Antioxidant vitamins and risk of gastric cancer: a case-control study in Portugal Nutr Cancer 55 2006 71 77 (Pubitemid 44477047)
74. M. Jenab, E. Riboli, and P. Ferrari Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European propsective investigation into cancer and nutrition Br J Cancer 95 2006 406 415 (Pubitemid 44187608)
75. S.A. Navarro Silvera, and T.E. Rohan Trace elements and cancer risk: a review of the epidemiological evidence Cancer Causes Control 18 2007 7 27 (Pubitemid 46020898)
76. J. Steevens, P.A. van der Brandt, and R.A. Goldbohm Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study Gastroenterology 138 2010 1704 1713
77. W.J. Blot, J.-Y. Li, and P.R. Taylor Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population J Natl Cancer Inst 85 1993 1483 1492 (Pubitemid 23269183)
78. Y.-L. Qiao, S.M. Dawsey, and F. Kamangar Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian general population nutrition intervention trial J Natl Cancer Inst 101 2009 507 518
79. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 1990 425 430
80. C. Muller, A.G. Bockhorn, and S. Klusmeier Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis Int J Oncol 12 1998 717 723 (Pubitemid 28097305)
81. M. Weis, C. Heeschen, and A.J. Glassford Statins have biphasic effects on angiogenesis Circulation 105 2002 739 745 (Pubitemid 34157379)
82. T. Kusama, M. Mukai, and T. Iwasaki 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis Gastroenterology 122 2002 308 317 (Pubitemid 34116983)
83. M.R. Graaf, A.B. Beiderbeck, and A.C.G. Egberts The risk of cancer in statin users J Clin Oncol 22 2004 2388 2394
84. J.A. Kaye, and H. Jick Statin use and cancer risk in the general Practice research database Br J Cancer 90 2004 635 637 (Pubitemid 38297203)
85. J. Hippisley-Cox, and C. Coupland Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database Br Med J 340 2010 c2197
86. J. Haukka, R. Sankila, and T. Klaukka Incidence of cancer and statin usage - record linkage study Int J Cancer 126 2010 279 284
87. D.R.L. Browning, and R.M. Martin Statins and risk of cancer: a systematic review and meta-analysis Int J Cancer 120 2006 833 843
88. J. Kuoppala, A. Lamminpaa, and E. Pukkala Statins and cancer: a systematic review and meta-analysis Eur J Cancer 44 2008 2122 2132